Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H WALTER

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
International Journal of Pharmaceutics|March 11, 2014
Cell viability of fibroblasts to pifenidone and sirolimus: a future concept for drug eluting stentsRobert F H Walter, Paul Zarogoulidis, Fabian D Mairinger, et al.
Applied Microbiology and Biotechnology|January 10, 2013
Evaluation of stable isotope fingerprinting techniques for the assessment of the predominant methanogenic pathways in anaerobic digestersM Nikolausz, R F H Walter, H Sträuber, et al.
British Journal of Cancer|February 11, 2015
MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53R F H Walter, F D Mairinger, S Ting, et al.
Pathology, Research and Practice|January 5, 2019
Setting out the frame conditions for feasible use of FFPE derived RNAJan Schmeller, Michael Wessolly, Elena Mairinger, et al.
Journal of Cancer|June 25, 2014
Activation of angiogenesis differs strongly between pulmonary carcinoids and neuroendocrine carinomas and is crucial for carcinoid tumourgenesisFabian D Mairinger, Robert F H Walter, Robert Werner, et al.
Future Oncology (London, England)|June 20, 2014
Mdm2 protein expression is strongly associated with survival in malignant pleural mesotheliomaFabian D Mairinger, Robert F H Walter, Saskia Ting, et al.
International Journal of Molecular Sciences|August 12, 2023
Cancer-Associated Fibroblasts Influence Survival in Pleural Mesothelioma: Digital Gene Expression Analysis and Supervised Machine Learning ModelSabrina Borchert, Alexander Mathilakathu, Alina Nath, et al.
Plos One|June 1, 2018
Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancerR F H Walter, P Rozynek, S Casjens, et al.
Journal of Oncology|January 14, 2020
Screening of Pleural Mesothelioma Cell Lines for Kinase Activity May Identify New Mechanisms of Therapy Resistance in Patients Receiving Platin-Based ChemotherapySabrina Borchert, Pia-Maria Suckrau, Michael Wessolly, et al.
Translational Lung Cancer Research|August 25, 2021
Mitogen signal-associated pathways, energy metabolism regulation, and mediation of tumor immunogenicity play essential roles in the cellular response of malignant pleural mesotheliomas to platinum-based treatment: a retrospective studyAlexander Mathilakathu, Sabrina Borchert, Michael Wessolly, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
International Journal of Pharmaceutics|March 11, 2014
Cell viability of fibroblasts to pifenidone and sirolimus: a future concept for drug eluting stentsRobert F H Walter, Paul Zarogoulidis, Fabian D Mairinger, et al.
Applied Microbiology and Biotechnology|January 10, 2013
Evaluation of stable isotope fingerprinting techniques for the assessment of the predominant methanogenic pathways in anaerobic digestersM Nikolausz, R F H Walter, H Sträuber, et al.
British Journal of Cancer|February 11, 2015
MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53R F H Walter, F D Mairinger, S Ting, et al.
Pathology, Research and Practice|January 5, 2019
Setting out the frame conditions for feasible use of FFPE derived RNAJan Schmeller, Michael Wessolly, Elena Mairinger, et al.
Journal of Cancer|June 25, 2014
Activation of angiogenesis differs strongly between pulmonary carcinoids and neuroendocrine carinomas and is crucial for carcinoid tumourgenesisFabian D Mairinger, Robert F H Walter, Robert Werner, et al.
Future Oncology (London, England)|June 20, 2014
Mdm2 protein expression is strongly associated with survival in malignant pleural mesotheliomaFabian D Mairinger, Robert F H Walter, Saskia Ting, et al.
International Journal of Molecular Sciences|August 12, 2023
Cancer-Associated Fibroblasts Influence Survival in Pleural Mesothelioma: Digital Gene Expression Analysis and Supervised Machine Learning ModelSabrina Borchert, Alexander Mathilakathu, Alina Nath, et al.
Plos One|June 1, 2018
Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancerR F H Walter, P Rozynek, S Casjens, et al.
Journal of Oncology|January 14, 2020
Screening of Pleural Mesothelioma Cell Lines for Kinase Activity May Identify New Mechanisms of Therapy Resistance in Patients Receiving Platin-Based ChemotherapySabrina Borchert, Pia-Maria Suckrau, Michael Wessolly, et al.
Translational Lung Cancer Research|August 25, 2021
Mitogen signal-associated pathways, energy metabolism regulation, and mediation of tumor immunogenicity play essential roles in the cellular response of malignant pleural mesotheliomas to platinum-based treatment: a retrospective studyAlexander Mathilakathu, Sabrina Borchert, Michael Wessolly, et al.
Pageof 2